ArticleBiomedicines2021

Real-Life Effectiveness of Mepolizumab on Forced Expiratory Flow between 25% and 75% of Forced Vital Capacity in Patients with Severe Eosinophilic Asthma.

Angelantonio Maglio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.